4.3 Article

Reducing survey burden: feasibility and validity of PROM IS measures in multiple sclerosis

Journal

MULTIPLE SCLEROSIS JOURNAL
Volume 20, Issue 8, Pages 1102-1111

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458513517279

Keywords

Computerized Adaptive Test; multiple sclerosis; outcome measurement; PROMIS; self-reporting; survey design; validation

Funding

  1. Oregon Clinical and Translational Research Institute (National Center for Research Resources) [UL1 RR024140]
  2. Oregon Clinical and Translational Research Institute (National Center for Advancing Translational Sciences of the National Institutes of Health (NIH))
  3. National Center for Complementary and Alternative Medicine of the NIH [2R25AT002878-05A1, AT002688]
  4. Agency for Healthcare Research Quality [5T32HS017582-05]
  5. Medical Research Foundation of Oregon

Ask authors/readers for more resources

Background: Patient-reported outcomes are important for clinical research and care, yet administering and scoring the questionnaires requires considerable effort and time. The Patient Reported Outcomes Measurement Information System (PROMIS) could considerably reduce administrative obstacles and lessen survey burden for participants. Objective: Assess the feasibility and validity of PROMIS, compared to commonly-used legacy measures for multiple sclerosis (MS). Methods: In this cross-sectional survey, 133 participants with confirmed MS completed legacy surveys and PROMIS Computerized Adaptive Tests (CATs) for depression, anxiety, pain, fatigue and physical function. We conducted a multi-trait, multi-method analysis and verified results with confirmatory factor analysis. Results: The correlations between PROMIS and the corresponding legacy measures were large (0.67 to 0.87). The multi-trait, multi-method criteria were generally well met, providing good evidence of the validity of PROMIS measures. PROMIS surveys asked fewer questions and required substantially less time to complete than the legacy scales. Conclusions: Our results provide evidence of the construct validity of PROMIS for use with MS patients. Several aspects of the PROMIS CATs made them an important resource, including: (a) less time was required to complete them; (b) missing data was reduced; and (c) the automatic scoring referenced the general population. Our findings support the use of PROMIS in MS research and may have broader implications for clinical care, as well.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available